A novel biosensing platform was developed by integrating a new ssDNA aptamer and graphene oxide (GO) for highly sensitive and selective detection of liver cancer biomarkers (alpha-fetoprotein, AFP). The key concept of this biosensing platform is that the fluorescence of dye-modified ssDNA can be effectively quenched by GO after forming the hybrid structure of graphene oxide-ssDNA (GO-ssDNA). The AFP can selectively react with GO-ssDNA and lead to the decomposition of GO-ssDNA, which results in the recovery of fluorescence, and an increase in fluorescence intensity with the increasing concentration of AFP in the range of 0 to 300 pg mL À1 . The linear range was obtained from 1 to 150 pg mL À1 and the detection limit was 0.909 pg mL
Introduction
Cancer is a frequently occurring disease involving abnormal cell growth with the potential to spread to another organ of the body; most cancer patients succumb to issues associated with metastasis of the primary cancer.
1 Cancer screening is an essential pathway for early detection of cancer and precancerous lesions. The detection and identication of cancer at the earliest stage could have great potential for improving therapeutic outcomes.
2 Cancer biomarkers such as proteins, nucleic acids, enzymes, inammatory factors, small biomolecules and extracellular matrix modulates can offer important information to achieve early diagnosis of cancer.
3,4
Among them, proteins are considered as biomarkers for diagnosis of a broad variety of cancers because of their overexpression in cancerous cells of cancers and the circulatory system.
5
Since the discovery of alpha-fetoprotein (AFP) by Abelev et al. in 1963, 6 AFP has been used as a classic cancer marker for the diagnosis of primary liver cancer, which is crucial for early diagnosis. Some methods have been developed for AFP determination such as immunology, 9 and uorescence spectroscopy. 10 The method of combining nanomolecule and uorescence spectroscopy is not only simple and highly sensitive but also suitable for realtime monitoring of changes in protein content of cancer markers. These new types of analytical tools for life science and biotechnology have been created by combining the highly specic recognition ability of biomolecules with the unique structural character of nanomaterials such as graphene oxide (GO). 11, 12 In particularly, GO as a substrate for a variety of transformations 13 has shown great potential in electronics and optoelectronics, 14 optics 15 and biosensing.
16
GO is an electronic hybrid material that features both conducting p-states from sp 2 carbon sites and a large energy gap (carrier transport gap) between the s-states of its sp 3 -bonded carbons. 17 The intrinsic advantages arise from the unique physical and chemical structure of GO. 18 The twodimensional sheet is equipped with a range of functional groups that can interact in an ion, covalent or non-covalent manner, so in principle it provides the highest extraction efficiency of biomolecules per unit area of virtually any material. The interactions of GO with biological molecules have been intensively studied in recent years 19 and the hybrid structure of GO with nucleic acids or proteins formed by covalently or non-covalent attachment have been used as biosensors 20 and drug transporters. 21 GO has recently been demonstrated to interact concurrently with single-stranded DNA (ssDNA) 22, 23 and uorescence quenching has been used as the basis of GO optical sensors for sensing biomolecules. 24, 25 It is well known that graphite carbon quenches uorescence from dye molecules adsorbed on its surfaces. Studies indicate that this quenching effect originates from uorescence resonance energy transfer, or non-radiative dipole-dipole coupling, between the uorescent species and GO. Its effectiveness in quenching uorescence affords advantages over alternative carbon materials such as nanodiamonds 26 and carbon nanotubes. 27 The ssDNA molecules form stable complexes with GO, supercial adsorption with them using p-stacking interactions between the nucleotide bases and the GO surface. This binding interaction of GO with ssDNA has provided the basis for its use in molecular recognition and detection of biomolecules.
28,29
In this work, a new ssDNA aptamer 30 was rstly combined with GO to construct a uorescence sensing platform for rapid and facile detection of AFP in the blood of patients with liver cancer. Aer the ssDNA was chemically modied with uorescent dye, the forming GO-ssDNA hybrid structure could be effectively quenched by GO. Since the binding ability of AFP and ssDNA was stronger than that of GO, the uorescence intensity can be recovered aer introducing AFP. Quantitative detection of AFP in buffer solution or serum according to the degree of uorescence recovery or increase by adding different concentrations of AFP, which showed improved performances compared with reported work and demonstrated great potential applications in clinical diagnosis and research.
Experimental
Reagents and chemicals
was purchased from Sangon Biotech (Shanghai, China) Co., Ltd. Fluorescence-quenching and hybridization assays FAM-ssDNA solution (500 nM) was incubated at 90 C for 5 min and then cooled down to the room temperature gradually. Different volumes of GO solution (0.5 mg mL À1 ) were mixed with 500 nM of FAM-ssDNA (20 mL) in 1.5 mL micro tube separately, and different volumes of 20 mM Tris-HCl buffer were added to make each nal volume 1 mL and kept at 37 C for 5 min. Finally, the solution was transferred to the uo-rescence cuvette (10 Â 10 mm) and the uorescence spectrum was measured three times under room temperature.
Detection of AFP
FAM-ssDNA solution (500 nM) was incubated for 5 min at 90 C in 20 mM Tris-HCl buffer and then cooled down gradually to the room temperature. Then, 20 mL GO solutions (0.5 mg mL À1 )
were mixed with 20 mL 500 nM of FAM-ssDNA in 1.5 mL Micro tube and incubated for 5 min. Different volumes (0-300 mL) of AFP (1 ng mL À1 ) were transferred into the above system and reacted for 10 min, nally moderate volume of Tris-HCl buffer was added to make each reaction solution 1 mL and mixed well. Finally, the uorescence emission spectrum was recorded from 500 nm to 700 nm with 488 nm excitation at room temperature.
Selective experiment
To verify the selectivity of the method for AFP, samples of BSA, CEA, PSA and their mixture with AFP were measured using the sameness conditions of AFP. The concentrations of BSA, CEA and PSA both were 1 ng mL
À1
, and the mixed sample contained 100 pg mL À1 AFP, 1 ng mL À1 CEA and 1 ng mL À1 PSA, respectively. Human serum samples were diluted with Tris-HCl buffer to a suitable concentration for AFP detection. Moreover, in order to verify the specicity of AFP, cell uorescence imaging analysis was performed in this experiment. AFP positive HepG2 cells and AFP negative BT474 cells were seeded into 35 mm CellBIND at an initial number of 2 Â 10 4 cells per well. Aer a 48 h culture, the cells were washed with PBS for 3 times. Subsequently, the cells were incubated with 500 nM FAM-ssDNA in MEM with 10% fetal bovine serum and 1% NEAA for 60 min, washed with PBS for 3 times again and then observed by laser confocal scanning microscopy. BT474 was incubated with 500 nM FAM-ssDNA in RPMI 1640 with 10% FBS.
Detection of AFP in serum
Typically, 20 mL of FAM-ssDNA (500 nM) was incubated with 20 mL of GO solution (0.5 mg mL À1 ) at room temperature for 10 minutes, then 10 mL of human serum containing different concentrations of AFP (0, 20, 40, 80, 130 pg mL À1 ) were transferred to the above solution. Subsequently, above mixture was uniformly mixed and reacted for 10 min. Finally, appropriate amount of Tris-HCl buffer was added to keep the nally volume at 1 mL and the uorescence spectra was recorded under room temperature.
Results and discussion
Detection principle of uorescent biosensor Fluorescence resonance energy transfer (FRET) is a special type of dynamic quenching mechanism that relies on the distancedependent transfer of energy from a donor molecule to an acceptor molecule. Energy transfer is likely to happen under the following conditions: 31 (1) the relative orientation of the donor and acceptor dipoles, (2) the extent of overlap of uorescence emission spectrum of the donor with the absorption spectrum of the acceptor, and (3) the distance between the donor and the acceptor is less than 7 nm. The energy transfer efficiency E is dened by the following equation
where r is the distance between donors and acceptors, and R 0 is the distance between donors and acceptors when the transfer efficiency is 50%. An approximatively inverse ratio exists between FRET efficiency and sixth power, and the typical value of R 0 is calculated to be at the nanoscale below 10 nm using overlap integral. As described in Scheme 1, without the addition of the target AFP, r between FAM-ssDNA and GO decreased gradually due to the p-p stacking effect, 32 near-eld energy communication occurs. The uorescence energy is transferred from FAM-ssDNA to GO resulting in uorescence quenching. Aer the introduction of AFP, FAM-ssDNA specically bound to AFP and released from the surface of GO, followed by the disappearing of the FRET and recovering of the uorescence signal.
Feasibility verication of bioassay
The uorescence emission spectra of the biosensor under different conditions are shown in Fig. 1 . The curve I is the uorescence emission spectrum before FAM-ssDNA quenching, and the curve IV is the quenching spectrum aer the GO added to the system of FAM-ssDNA. According to Fig. 1 , 70% of the uorescence signal was quenched aer adding GO. Curve II and curve III are the uorescence spectra of the target proteins AFP and GO respectively added in opposite order by the curve I, which indicates whether the addition order of AFP and GO, the uorescence signal can be restored to a certain level. This suggests that the constructed uorescent biosensor can be used for AFP detection. It also concluded that the addition order of GO and AFP might inuence the results. This considered that with the addition of AFP rst, FAM-ssDNA will preferentially combine with AFP to form a stable structure, resulting in a longer distance r between FAM-ssDNA and GO and a lessened FRET effect. The sensitivity of the biosensor can be further increased if a magnication strategy can be used to maximize the release of the quenched uorescence signal.
Characterization of GO-ssDNA
In this work, stable p-p stacking is formed between the nucleobases and GO surface which made GO playing as a powerful role in adsorption and quenching the uorescence of ssDNA. Morphology the materials were studied by TEM. It can be seen that GO was thin nanosheet like scarf (Fig. 2a) and the ssDNA have accumulated on the surface of GO (Fig. 2b) . Due to the aromatic rings of the nucleobases and those of the GO, ssDNA can be adsorbed onto the surface of the materials. TEM showed the ssDNA was adsorbed on the surface of GO in the uorescence sensing platform which was consistent with the research already reported.
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The GO, ssDNA, GO-ssDNA were analyzed by FT-IR respectively (Fig. 3) . The peaks nearby 3230 cm À1 were assigned to the IR absorption peaks of benzene ring and OH. In the spectrum of GO, the peak at 1630 cm À1 and 1731 cm À1 were assigned to the stretching vibration of C]C and C]O bond, respectively. The FT-IR spectrum of GO-ssDNA exhibits typical peaks for both GO and ssDNA. The weak band at 2396 cm À1 showed the common characteristic of ssDNA could be assigned to the structure of -PH. The C-H deformation vibration of GO appears at 685-715 cm À1 frequency region of GO-ssDNA composites. All of these indicated that ssDNA was adsorbed on the surface of GO.
Optimization of experimental conditions
GO is a kind of broad surface area nanomaterial with benecial water solubility due to the hydrophilic groups. It is eventful to optimize the concentration of GO cautiously for assays. Low concentration of GO may result in a narrower detection range for AFP, while excess of GO will combine with target protein, resulting in a lack of sensitivity for AFP detection. FAM-ssDNA was absorbed rapidly when approached the surface of GO because of the p-p stacking interactions between GO and nucleotide bases. Aerwards, the uorescence of FAM was efficiently quenched on account of FRET between FAM and GO. The concentration of GO was optimized and the results were shown in Fig. 4 . As shown in Fig. 4a , the uorescence intensity of FAM-ssDNA at 520 nm decreased with the increasing concentration of GO. The uorescence of 10 nM FAM-ssDNA was quenched at least 95% compared with the original intensity ( Fig. 4a-1 ) by 10 mg mL À1 of GO (Fig. 4a-5 ), indicating the strong quenching effect of GO on the uorescence of FAM. With the addition of AFP, the FAM-ssDNA, acting as an aptamer, can combine with AFP forming a stable structure. This decreases the interaction between the DNA nucleotides and GO owing to the hydrophilicity of the phosphate backbone of the structure p-p stacking interaction, which leads to the uorescence recovery. Fig. 4b shows the relationship between the (F 0 À F)/F 0 value and the concentration of GO (F 0 and F are the uorescence intensities at 520 nm without and with GO, respectively). The (F 0 À F)/F 0 tended to a maximum value at 10 mg mL À1 and the quenching efficiency of the uorescence were basically stable (Fig. 4b) . Therefore, a GO concentration of 10 mg mL À1 was employed in this study. The different incubation time of FAM-ssDNA and GO was also investigated. The (F 0 À F)/F 0 value increased speedily as the incubation time increased from 0 to 10 min according to Fig. 4c , then it remained at a relatively stable value from 10 min to 25 min, which indicate that the specic interaction of FAMssDNA and GO had reached an equilibrium. However, the uorescence quenching efficiency ((F 0 À F)/F 0 ) for the assay of FAM-ssDNA upon addition of GO is decreasing gradually aer 15 min (Fig. 4d) , it could be that the conjugate function up to pp base stacking force is in a dynamic equilibrium state. Therefore, 10 min was selected as the optimal incubation time.
Optimization of conditions using the aptasensor
To achieve the best results for the aptasensor, the experimental conditions were optimized, included the pH of the buffer solution, the incubation time and the incubation temperature.
The pH of the buffer solution is an important parameter for the aptasensor. A series of solution was tested with the pH from 6.5 to 8.0. As shown in Fig. S1a , † with increasing pH from 6.5 to 7.0, the F/F 0 increased, then the F/F 0 decreased at the pH 8.0, but the change is not obvious from 6.5 to 8.0. In order to make the detection of actual samples more convenient, the optimal pH 7.4 was used for further experiment. 
Feasibility and quantitative analysis of AFP detection
In order to investigate the feasibility of AFP detection based on the aptasensor of FAM-ssDNA, the uorescence intensity of FAM-ssDNA/GO under different conditions was measured.
Since the 5 0 end of the nucleic acid was labeled with FAM, the ssDNA emit green light with high intensity at the wavelength of 520 nm. The uorescence intensity of FAM-ssDNA decreased rapidly in the addition of GO, indicating uorescent nucleic acid probe adsorbed strongly on the surface of GO, resulting in the FRET. With the addition of AFP, the uorescence intensity of the system gradually recovered (Fig. 5a) , indicating that the combination of FAM-ssDNA and AFP kept it away from the GO surface. FRET could not occur and the uorescence gradually recovered.
To test whether the advance method could be used for quantitative detection of AFP, the uorescence intensity at different concentrations of AFP under the optimized experimental conditions was measured. As showed in Fig. 5a , with the increase of AFP concentration gradually from 0 to 300 pg mL À1 , the uorescence intensity of the system also increases. As displayed in Fig. 5b , the relationship between F/F 0 (F and F 0 are the uorescence intensities in the presence and absence of AFP, respectively) and the AFP concentration performed a good linear relationship (y ¼ 0.146x + 0.8359, R 2 ¼ 0.9946) in the range of 1-150 pg mL À1 (Fig. 5b, inset) . The limit of detection (LOD) was calculated to be 0.909 pg mL À1 on the basis of 3SB/ b (SB is the standard deviation of the blank solution and b is the slope of the analytical curve). These results all demonstrated that the advance method could be used for the quantitative detection of AFP in aqueous solutions.
Selectivity of the uorescent sensing platform towards different cancer marker proteins
For determination of AFP in biological samples, the selectivity of the proposed method was investigated using the sensing platform against various structure analogues, such as CEA, PSA and the mixed sample under the same experimental conditions. The results showed that neither CEA nor PSA inuenced the ). F 0 and F are the fluorescence intensities without and with AFP, respectively. System contains 10 nM FAM-ssDNA and 10 mg mL À1 GO. The excitation and emission wavelengths were 488 nm and 520 nm. detection of AFP (Fig. 6 ). As showed in Fig. 6b , comparing with the blank system, almost no difference can be observed on the uorescence of the system for CEA (1 ng mL À1 ) and PSA (1 ng mL À1 ), while a signicant uorescence decrease is observed for AFP (0.1 ng mL À1 ). Moreover, the F/F 0 value of the mixed sample was similar to that of AFP. Therefore, the sensing platform was highly specic to AFP detection, which was further conrmed by the slight uorescence response to the coexistence of CEA (1 ng mL À1 ) and PSA (1 ng mL À1 ).
Additionally, HepG2 and BT474 cells were stained directly with FAM-ssDNA to conrm the binding of ssDNA to AFP. As expected, HepG2 (Fig. S2a †) was positive and BT474 (Fig. S2a †) was negative. FAM-ssDNA was specically targeted to AFP (Fig. S2b †) . FAM-ssDNA stained images were brighter, homogeneous and accurate, and no specic staining was found in BT474 using FAM-ssDNA (Fig. S2b †) . All of these results indicate that FAM-ssDNA specically targets AFP in live cell and has excellent uorescence staining intensity and provide support for the specic quantitative detection of AFP in cell and even in vivo.
Detection of AFP in complex human serum
The established method was applied to detect AFP in spiked human serum samples, which aimed at investigating the ability of the method used in the complicated matrix. Serum was considered as a complicated biological matrix, which is obtained by removal of brinogen or other clotting factors in plasma. Serum brought a lot of complex matrix to our system, especially many kinds of proteins. These complicated materials in serum stabilized the uorescence intensity in some way and on the other hand, they might also participate in the nonspecic adsorption competition with each other onto the surface of GO. The present method not only responses to AFP effectively in buffer solution but also shows excellent analytical efficiency in human serum.
A standard addition method was applied to determine AFP in 100-fold diluted human serum. The results demonstrate that the uorescence intensity quantitatively increased with the addition of AFP. About 25-400 ng mL À1 AFP exists in the plasma of patients with hepatocellular carcinoma, and the method could be used for detecting different concentrations of AFP in serum. To evaluate the clinical application potential of the proposed method, a set of serum with different concentrations of AFP was assayed following the procedure mentioned above.
As showed in Table 1 , the recoveries (between 96.00% and 103.65%) were acceptable. These results indicated that this aptasensor had promised analytical applications in clinical diagnosis.
The biosensing platform based on FAM-ssDNA/GO in this study to AFP in human serum was compared with other methods reported in previously literature, listed in Table 2 . As can be seen from Table 2 , several methods of AFP detection have also been applied, but most of them require a large amount of experimental materials and complicated instruments. The uorescent biosensing platform based on GOssDNA for the detection of AFP has signicant advantages over the other methods. First of all, this experiment was the rst application of ssDNA to build a biosensor platform which solved the problems of immune contamination by antibodies. Moreover, the use of uorescence quenching aer recovery means that it is easy to operate and greatly shorten the time of the experiment. Last and most important, the LOD for AFP in this method was calculated to be 0.909 pg mL À1 , which is lower than previously reported methods (Table 2) .
Conclusions
In summary, we propose a uorescence biosensor platform based on GO-ssDNA for AFP early detection, where the adding of AFP can active the recovery of uorescence on the dye of ssDNA quenched by GO. The feasibility of the proposed method was conrmed by a set of comparison experiments and the optimized conditions were carefully selected by systematically study. A good linear relationship was found between F/F 0 and the concentration of AFP in the range of 1-150 pg mL À1 .
Moreover, the proposed method is suitable for the detection of AFP in complex human serum. The limit of detection for AFP with concentration of 0.909 pg mL À1 can be detected by using GO-ssDNA uorescence biosensor platform. All above results suggest our proposed biosensor platform can selectively detect AFP with high sensitivity both in buffer and in complex human serum, which provides great clues for its potential use in AFPrelated clinical diagnosis and this biosensing platform could be applied to any uorescently tagged ssDNA to identify and detection their target cancer markers. The proposed method has a high sensitivity of detection, and it is possible to nd the difference in alpha-fetoprotein, which is promising as a detection method for early diagnosis of liver cancer.
Conflicts of interest
There are no conicts to declare.
